Shares of Cencora Inc. rose 2.93% to $295.04 Thursday, on what proved to be an all-around favorable trading session for the ...

The long-awaited decision is a major blow to an ambitious plan that includes overdose prevention centers; a final outcome ...

Upon assuming his role as chief information and technology officer at Cincinnati-based Bon Secours Mercy Health, Edmund Siy emphasized one key principle: technology should always align with the ...

Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

Cencora gets a buy rating, agreeing with today's consensus from Wall St. The sector and macro environment point to continued demand for the healthcare supplies and niche specialty drugs Cencora ...

The Justice Department also filed a lawsuit against Cencora in December 2022. Federal prosecutors accused the company of failing to report hundreds of thousands of suspicious orders to the Drug ...

Cencora's shares saw a slight uptick following ... More news from Barchart Trump Wants to Shut Down the Department of Education. Why That Would Be Good News for SoFi Stock 2 Juicy Dividend ...

The efforts, led by Elon Musk’s Department of Government Efficiency ... Distributors such as McKesson Corp. and Cencora Inc. could face disruption, with the analysts noting government spending ...

Given January’s Department of Justice (DOJ) civil suit over improper dispensing of opioids and and other unlawful medications over more than a decade, with possible penalties in the billions, ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...